IOVA

Iovance Biotherapeutics Inc.

Price

$7.99

return (12m)

207.31%

p/e

-10.18

p/bv

4.00

DIVIDEND YIELD

0.00%

IOVA price

Iovance Biotherapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IOVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

52.34%

3 months

115.95%

1 year

207.31%

2 years

-29.23%

5 years

-64.12%

10 years

-12.68%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals IOVA

Valuation

P/E

-10.18

Sector -4.38

Industry -4.38

P/BV

4.00

Sector 2.02

Industry 2.02

P/Revenue (PSR)

9.07

Sector -4.40

Industry -4.40

EV/EBITDA

-68.35

Sector -263.09

Industry -263.09

EV/EBIT

-54.65

Sector -702.90

Industry -702.90

P/EBITDA

-11.73

Sector -4.39

Industry -4.39

P/EBIT

-9.95

Sector -4.73

Industry -4.73

P/Total Assets

3.22

Sector 1.49

Industry 1.49

P/Net Current Assets

10.35

Sector -11.70

Industry -11.70

P/Working Capital

8.25

Sector -3.19

Industry -3.19

EPS

-0.64

Sector -2.14

Industry -2.14

BVPS

1.64

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

48.40%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-41.79%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-52.27%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-91.14%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-89.09%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.11

Sector 0.03

Industry 0.03

Profitability

ROE

-39.33%

Sector -65.14%

Industry -65.14%

ROA

-31.62%

Sector -65.53%

Industry -65.53%

ROIC

-31.89%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.34

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.67

Sector -6.07

Industry -6.07

Net Debt / EBIT

2.13

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.15

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.80

Sector 0.41

Industry 0.41

Liabilities/Assets

0.20

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-3.29%

Sector -

Industry -

Fundamentals IOVA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IOVA Iovance Biotherapeutics Inc.	$7.99	219.60%	0.00%	-10.18	4.00	-39.33%	-89.09%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IOVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Iovance Biotherapeutics

Iovance Biotherapeutics Inc.

Average Investor10 user rating

4.0 (2 people)

United States

19 years

Founded: 2007

2010

Time since IPO - 16 years

241

Employees

Iovance Biotherapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.95 billion, with shareholders equity totaling $736.04 million.

The company employs approximately 241 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Iovance Biotherapeutics Inc. reported $324.96 million in revenue, generating net income of $-289.51 million.

Key financial metrics include a P/E ratio of -10.18, a price-to-book (P/B) ratio of 4.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IOVA.

Market cap

$2.95 billion

Net worth

$736.04 million

$736,040,000.00

Assets

$915.53 million

$915,530,000.00

Total Shares Outstanding

450.00 million

450,000,000

Average Daily Trading Volume

$16.67 million

$16,672,608.00

Sector

Health Care

Industry

Biotechnology

IOVA

IOVA revenue and profits

Financial Results IOVA

DRAG THE FRAME TO SEE MORE DATA

IOVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Iovance Biotherapeutics (IOVA) today?

A cotação de Iovance Biotherapeutics (IOVA) hoje está em US$ 7.99, com uma variação de 207.31% em relação ao último ano. A cotação de Iovance Biotherapeutics (IOVA) iniciou o ano negociando na casa dos US$ 2.73 e hoje está em US$ 7.99. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Iovance Biotherapeutics (IOVA) e dados de ações do Ibovespa e mercados internacionais.

Quando Iovance Biotherapeutics (IOVA) paga dividendos?

Iovance Biotherapeutics (IOVA) não distribuiu dividendos no último ano.

Is Iovance Biotherapeutics (IOVA) a good investment?

Atualmente, Iovance Biotherapeutics (IOVA) está cotada a US$ 7.99, com um P/L de -10.18, representando um desvio de -530% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 207.31 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 207.31%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Iovance Biotherapeutics (IOVA) stock?

Investir em ações de Iovance Biotherapeutics (IOVA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Iovance Biotherapeutics (IOVA) yield today?

A rentabilidade de Iovance Biotherapeutics (IOVA) foi de 52.34% no último mês, 207.31% no último ano e -64.12% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Iovance Biotherapeutics (IOVA) hoje, o investimento total seria de US$ 799.00, com base na cotação atual de US$ 7.99.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,455.41
Em 5 anos: US$ 286.68
Em 10 anos: US$ 697.69

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IOVA

Iovance Biotherapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IOVA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING IOVA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Iovance Biotherapeutics

Iovance Biotherapeutics Inc.

United States

19 years

2010

241

PROFIT X PRICE IOVA

Financial Results IOVA

IOVA cash flow

Asset, Revenue and Profit Growth - IOVA

IOVA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions